Covered recipient · General Payments record
LEONARD J APPLEMAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$7,096.88
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $959.10 | 11 |
| Education | $18.09 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $432.93 | 4 |
| Acerta Pharma LLC | $377.27 | 5 |
| PFIZER INC. | $135.00 | 1 |
| Merck Sharp & Dohme Corporation | $18.09 | 1 |
| Tempus AI, Inc | $13.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $37.11 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105804063 | CMS |
| AstraZeneca Pharmaceuticals LP | $52.94 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104232919 | CMS |
| AstraZeneca Pharmaceuticals LP | $85.17 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104294864 | CMS |
| AstraZeneca Pharmaceuticals LP | $86.26 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104581162 | CMS |
| AstraZeneca Pharmaceuticals LP | $115.79 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105557058 | CMS |
| Exelixis Inc. | $44.44 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138560904 | CMS |
| Exelixis Inc. | $68.66 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138560902 | CMS |
| Exelixis Inc. | $174.00 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138560906 | CMS |
| Exelixis Inc. | $145.83 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138560908 | CMS |
| Merck Sharp & Dohme LLC | $18.09 | 11/03/2024 | Education | Undisputed | 01/23/2026 | 1141559435 | CMS |
| PFIZER INC. | $135.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131484588 | CMS |
| Tempus AI, Inc | $13.90 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150160398 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.